Innovation is critical to enabling NHS England to achieve the ambitions set out in the Mandate, to ramp up the pace and scale of change, and deliver better outcomes for patients across all five domains of the NHS Outcomes Framework. The NHS remains a major investor and wealth creator in the UK, and in science, technology and engineering in particular.
The Board’s objective is to ensure that the new commissioning system promotes and support participation of the NHS in research, translating scientific developments into benefits for patients, and contributing to economic growth by exporting innovation and expertise internationally. The Innovation programme is the only mainstream activity in NHS England that directly supports delivery of these benefits.
Formed in response to the Accelerated Access Review published in October 2016, the Accelerated Access Collaborative brings together industry, government, regulators, patients and the NHS to remove barriers and accelerate the introduction of ground-breaking new treatments and diagnostics which can transform care.